Wendy Stock, MDProfessor of MedicineDr. Wendy Stock is an authority in the medical management of all types of leukemia and myelodysplastic syndromes. She collaborates with other oncologists around the world through the National Cancer Institute and the Cancer and Leukemia Group B to help identify and develop better approaches to chemotherapy and other cancer treatments. Dr. Stock's laboratory focuses on studies to determine the clinical significance of the molecular detection and monitoring of minimal residual disease (MRD) states following treatment for leukemia and lymphoma. The laboratory is a national reference laboratory for several of these studies. Dr. Stock is also developing novel technology to measure tyrosine kinase activity in leukemia cells as a method for predicting response to treatment with novel targeted kinase inhibitors. She serves on the editorial board of the Journal of Clinical Oncology and has published papers and reviews in many esteemed medical journals. She has also spoken at international and national conferences on leukemia. Practice LocationsCenter for Advanced Medicine
The University of Chicago Medicine
Year Started Practice1985 Board CertificationsInternal Medicine
Medical SchoolRush Medical College, Chicago Residency and FellowshipThe University of Chicago Medicine Languages SpokenEnglish
wstock@medicine.bsd.uchicago.edu Office Phone(773) 834-8982 Office Fax(773) 702-0963 Office Postal AddressWendy Stock, MD
|
Clinical Interests
Request an appointment online
Physicians, contact the
More About Dr. StockDr. Stock is the co-director of the Adolescent and Young Adult Cancer (AYA) Program at the University of Chicago Medicine. Read how the clinic’s first patient, 24-year-old Jenn Georges, benefited from a clinical trail designed to battle leukemia in this distinct patient group.
Selected PublicationsView a partial list of Dr. Stock's publications through the National Library of Medicine's PubMed online database. |


